4//SEC Filing
Metcalfe David A 4
Accession 0001209191-22-054850
CIK 0000708818other
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 5:52 PM ET
Size
11.0 KB
Accession
0001209191-22-054850
Insider Transaction Report
Form 4
Metcalfe David A
Chief Technology Officer
Transactions
- Tax Payment
Common Stock
2022-10-27$19.02/sh−6,091$115,851→ 142,685 total - Sale
Common Stock
2022-10-26$20.21/sh−32,372$654,173→ 148,776 total - Exercise/Conversion
Common Stock
2022-10-26$14.20/sh+32,372$459,682→ 181,148 total - Exercise/Conversion
Stock Option (right to buy)
2022-10-26−32,372→ 117,628 totalExercise: $14.20Exp: 2024-02-01→ Common Stock (32,372 underlying)
Footnotes (4)
- [F1]Pursuant to a 10b5-1(c) plan adopted by the reporting person on March 15, 2022.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.415. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its stockholders upon request.
- [F3]Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock.
- [F4]Original grant of 200,000 options granted on 2/1/2016 vested in four equal, annual installments beginning 2/1/2017.
Documents
Issuer
NEXTGEN HEALTHCARE, INC.
CIK 0000708818
Entity typeother
Related Parties
1- filerCIK 0001664295
Filing Metadata
- Form type
- 4
- Filed
- Oct 27, 8:00 PM ET
- Accepted
- Oct 28, 5:52 PM ET
- Size
- 11.0 KB